HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum Endotoxins and Flagellin and Risk of Colorectal Cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.

AbstractBACKGROUND:
Chronic inflammation and oxidative stress are thought to be involved in colorectal cancer development. These processes may contribute to leakage of bacterial products, such as lipopolysaccharide (LPS) and flagellin, across the gut barrier. The objective of this study, nested within a prospective cohort, was to examine associations between circulating LPS and flagellin serum antibody levels and colorectal cancer risk.
METHODS:
A total of 1,065 incident colorectal cancer cases (colon, n = 667; rectal, n = 398) were matched (1:1) to control subjects. Serum flagellin- and LPS-specific IgA and IgG levels were quantitated by ELISA. Multivariable conditional logistic regression models were used to calculate ORs and 95% confidence intervals (CI), adjusting for multiple relevant confouding factors.
RESULTS:
Overall, elevated anti-LPS and anti-flagellin biomarker levels were not associated with colorectal cancer risk. After testing potential interactions by various factors relevant for colorectal cancer risk and anti-LPS and anti-flagellin, sex was identified as a statistically significant interaction factor (Pinteraction < 0.05 for all the biomarkers). Analyses stratified by sex showed a statistically significant positive colorectal cancer risk association for men (fully-adjusted OR for highest vs. lowest quartile for total anti-LPS + flagellin, 1.66; 95% CI, 1.10-2.51; Ptrend, 0.049), whereas a borderline statistically significant inverse association was observed for women (fully-adjusted OR, 0.70; 95% CI, 0.47-1.02; Ptrend, 0.18).
CONCLUSION:
In this prospective study on European populations, we found bacterial exposure levels to be positively associated to colorectal cancer risk among men, whereas in women, a possible inverse association may exist.
IMPACT:
Further studies are warranted to better clarify these preliminary observations.
AuthorsSo Yeon Kong, Hao Quang Tran, Andrew T Gewirtz, Gail McKeown-Eyssen, Veronika Fedirko, Isabelle Romieu, Anne Tjønneland, Anja Olsen, Kim Overvad, Marie-Christine Boutron-Ruault, Nadia Bastide, Aurélie Affret, Tilman Kühn, Rudolf Kaaks, Heiner Boeing, Krasimira Aleksandrova, Antonia Trichopoulou, Maria Kritikou, Effie Vasilopoulou, Domenico Palli, Vittorio Krogh, Amalia Mattiello, Rosario Tumino, Alessio Naccarati, H B Bueno-de-Mesquita, Petra H Peeters, Elisabete Weiderpass, J Ramón Quirós, Núria Sala, María-José Sánchez, José María Huerta Castaño, Aurelio Barricarte, Miren Dorronsoro, Mårten Werner, Nicholas J Wareham, Kay-Tee Khaw, Kathryn E Bradbury, Heinz Freisling, Faidra Stavropoulou, Pietro Ferrari, Marc J Gunter, Amanda J Cross, Elio Riboli, W Robert Bruce, Mazda Jenab
JournalCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (Cancer Epidemiol Biomarkers Prev) Vol. 25 Issue 2 Pg. 291-301 (Feb 2016) ISSN: 1538-7755 [Electronic] United States
PMID26823475 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright©2016 American Association for Cancer Research.
Chemical References
  • Biomarkers
  • Endotoxins
  • Flagellin
Topics
  • Biomarkers (blood)
  • Cohort Studies
  • Colorectal Neoplasms (blood, etiology)
  • Endotoxins (blood)
  • Europe
  • Female
  • Flagellin (blood)
  • Humans
  • Male
  • Nutrition Assessment
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: